Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 13,548 shares at $48.11 ($652K) on 2015-04-01, disclosed to the SEC on 2015-04-02.
Scheduled sale ($652k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.11 | 13,148 | $633K | 97.0% |
| 2 | $49.15 | 400 | $20K | 3.0% |
| Total | $48.14 avg | 13,548 | $652K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |